drugset / Trial / NCT04930809
Single and Multiple Dose Study of VER-01 in Healthy Volunteers
Non-randomizedSequentialOpen-labelTreatment
Summary
Evaluation of pharmacokinetics, tolerability and safety of VER-01 in healthy volunteers
Timeline
- Start
- 2021-11-25
- Primary completion
- 2022-07-04
- Completion
- 2022-07-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | VER-01 | Unknown | 2.5 mg | Oral |
| Subject | VER-01 | Unknown | 5 mg | Oral |
| Subject | VER-01 | Unknown | 10 mg | Oral |
| Subject | VER-01 | Unknown | 12.5 mg | Oral |
| Subject | VER-01 | Unknown | 20 mg | Oral |
| Subject | VER-01 | Unknown | 20.5 mg | Oral |
Indications
No indication recorded.